Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	53.53	69.22	84.59	76.2	63.13	85.29
Short-Term Investments	40.86	31.75	11.35	4.87	18.98	8.1
Cash & Short-Term Investments	94.39	100.97	95.94	81.07	82.11	93.39
Cash Growth	-2.42%	5.24%	18.34%	-1.26%	-12.08%	-16.35%
Accounts Receivable	33.57	32.01	47.84	40.35	32.53	25.54
Other Receivables	-	-	-	1.92	-	-
Receivables	33.57	32.01	47.84	42.27	32.53	25.54
Inventory	9.48	8.72	7.08	4.53	7.11	3.45
Prepaid Expenses	1.57	1.83	2.48	2.62	8.98	11.26
Restricted Cash	2.09	-	-	-	8.85	8.85
Other Current Assets	2.49	4.13	2.85	3.79	0.45	3.64
Total Current Assets	143.58	147.66	156.19	134.28	140.02	146.14
Property, Plant & Equipment	6.45	5.09	8.65	12.51	15.77	18.89
Other Intangible Assets	43.83	51.13	60.87	70.61	66.13	74.14
Long-Term Deferred Tax Assets	7.08	7.08	-	-	-	-
Long-Term Deferred Charges	0.07	0.1	0.21	-	0.58	0.96
Other Long-Term Assets	1.85	2.27	4.62	4.66	4.09	4.1
Total Assets	202.86	213.33	230.53	222.06	226.59	244.22
Accounts Payable	6.39	5.51	6.89	6.44	11.17	12.08
Accrued Expenses	25.82	26.07	35.63	32.73	24.03	29.59
Current Portion of Long-Term Debt	33.72	45.33	34	-	-	14.29
Current Portion of Leases	2.47	5.54	4.8	4.14	3.57	3.09
Other Current Liabilities	14.34	13.66	18.07	34.17	70.81	55.21
Total Current Liabilities	82.73	96.11	99.38	77.48	109.59	114.26
Long-Term Debt	-	21.72	65.66	98.31	97.09	84.03
Long-Term Leases	4.87	1.49	7.03	11.83	15.98	19.55
Other Long-Term Liabilities	-	1.88	5.01	12.83	6.38	32.34
Total Liabilities	87.59	121.21	177.09	200.45	229.03	250.17
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,412	1,407	1,399	1,388	1,364	1,332
Retained Earnings	-1,297	-1,315	-1,345	-1,367	-1,367	-1,338
Comprehensive Income & Other	0.02	0.01	-0	-	-0	-
Shareholders' Equity	115.27	92.13	53.44	21.61	-2.45	-5.95
Total Liabilities & Equity	202.86	213.33	230.53	222.06	226.59	244.22
Total Debt	41.05	74.08	111.49	114.28	116.64	120.95
Net Cash (Debt)	53.34	26.88	-15.55	-33.21	-34.54	-27.57
Net Cash Growth	415.08%	-	-	-	-	-
Net Cash Per Share	1.06	0.55	-0.33	-0.74	-0.85	-0.70
Filing Date Shares Outstanding	50.39	49.61	48.21	46.64	41.33	40.26
Total Common Shares Outstanding	50.38	49.11	47.65	46.35	41.18	40.09
Working Capital	60.85	51.55	56.8	56.8	30.44	31.88
Book Value Per Share	2.29	1.88	1.12	0.47	-0.06	-0.15
Tangible Book Value	71.44	40.99	-7.43	-49	-68.57	-80.09
Tangible Book Value Per Share	1.42	0.83	-0.16	-1.06	-1.67	-2.00
Machinery	3.12	4.6	4.76	4.79	4.84	4.85
Leasehold Improvements	3.78	3.78	3.78	3.78	3.78	3.78

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q